SAKK / Astellas GU-Oncology Award 2018
The future of oncology is fuelled by efforts of outstanding researchers and their research teams. Innovative preclinical and clinical research projects will continuously improve our knowledge in oncology and address emerging challenges.
Research is a continuous professional and personal commitment, therefore, SAKK’s and Astellas’ intent is to motivate and honor young researcher on this important journey.
To further preclinical and clinical oncology research in Switzerland, SAKK and Astellas team up to confer for the first time a Swiss GU-Oncology Award. A researcher will be awarded as representative of a research group or project for an outstanding scientific and/or clinical achievement documented by a scientific publication (published paper or accepted manuscript in a peer-reviewed journal).
The focus of the SAKK / Astellas GU-Oncology Award lies on potential tangible improvements for patient management and outcomes in the treatment of genitourinary cancers.
The award is endowed with CHF 30’000.– and should encourage the continuation of research activities. Hence the awarded sum is to be used for ongoing and future research within the respective research group or project.
Call for Applications Closed
Please note that the call for applications has been closed on
Sunday, September 30th, 2018.
An independent jury of experts, elected by the SAKK president, will evaluate the submitted applications based on (i) alignment with the scope of the award, (ii) scientific quality, (iii) national and (iv) international (future) scientific and/or clinical impact, and (v) innovative potential and novelty.
For more details please view the applicable Award Rules.
The winner of the SAKK / Astellas GU-Oncology Award 2018 will be announced and awarded during the next SAKK Semi-Annual Meeting, taking place at the Marriott Hotel in Zurich on November 22nd, 2018.
Astellas Pharma AG distributes the SAKK / Astellas GU-Oncology Award with the support of the Swiss Group of Clinical Cancer Research (SAKK) and the support of an independent jury at the SAKK Semi-Annual Meeting, taking place at the Marriott Hotel in Zurich on November 22nd, 2018. The award will be conferred to an eligible candidate, who may be a surgeon, physician or scientist, active in genitourinary oncology research within Switzerland. The research project must have been accepted or published in a peer-reviewed journal within the past 24 months (until application deadline). The winner will be awarded as representative of a research group or project for outstanding scientific and/or clinical achievements within the thematic focus of the SAKK / Astellas GU-Oncology Award 2018.
We cordially congratulate the winner of the third SAKK / Astellas GU-Oncology Award 2018, Dr. David Christian Müller, for his entitled published work: “Donor-derived, metastatic urothelial cancer after kidney-transplantation associated with a potentially oncogenic BK polyomavirus”
The award has been announced the 22nd of November 2018, at the semi-annual SAKK meeting in Zürich.
For further information, please click on this link.